SCHEMBL1962264

SCHEMBL1962264

CCCCCCCCCCCCCCC(C)C(OP(=O)([O-])OCC[N+](C)(C)C)[C@H](CO)OCCCCC(=O)OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.48
PLA2G1B P04054 1/20 0.48
PLA2G2A P14555 1/20 0.48
NR5A2 O00482 1/20 0.48
NR5A1 Q13285 1/20 0.48
RECQL P46063 1/20 0.47
LMNA P02545 3/20 0.46
MAPT P10636 3/20 0.46
ESR1 P03372 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
CDC25A P30304 1/20 0.46
AGTR1 P30556 1/20 0.46
AKT1 P31749 1/20 0.46
ADRA1A P35348 1/20 0.46
KCNH2 Q12809 1/20 0.46
PLA2G10 O15496 1/20 0.46
MAPK1 P28482 4/20 0.46
MEN1 O00255 2/20 0.46
GMNN O75496 2/20 0.46
BLM P54132 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1964054 0.91 RECQL (0.53) SMN1; SMN2PLA2G1BPLA2G2ANR5A2NR5A1
SCHEMBL1965933 0.91 RECQL (0.53) SMN1; SMN2PLA2G1BPLA2G2ANR5A2NR5A1
SCHEMBL1963302 0.90 SMN1; SMN2 (0.50) SMN1; SMN2PLA2G1BPLA2G2ANR5A2NR5A1
SCHEMBL1965779 0.90 SMN1; SMN2 (0.50) SMN1; SMN2PLA2G1BPLA2G2ANR5A2NR5A1
SCHEMBL1965886 0.90 SMN1; SMN2 (0.50) SMN1; SMN2PLA2G1BPLA2G2ANR5A2NR5A1
SCHEMBL1962755 0.87 SMN1; SMN2 (0.48) SMN1; SMN2PLA2G1BPLA2G2ANR5A2NR5A1
SCHEMBL1966963 0.85 SMN1; SMN2 (0.44) SMN1; SMN2PLA2G1BPLA2G2ANR5A2NR5A1
SCHEMBL2230558 0.81 SMN1; SMN2 (0.57) SMN1; SMN2PLA2G1BPLA2G2ANR5A2NR5A1
SCHEMBL17786141 0.80 RECQL (0.56) SMN1; SMN2PLA2G1BPLA2G2ANR5A2NR5A1
SCHEMBL17786136 0.80 RECQL (0.56) SMN1; SMN2PLA2G1BPLA2G2ANR5A2NR5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2348866-A1 OXIDIZED LIPID COMPOUNDS AND USES THEREOF Vascular Biogenics Ltd. (IL) 2011-08-03 EP disclosed
WO-2010052718-A9 OXIDIZED LIPID COMPOUNDS AND USES THEREOF VASCULAR BIOGENICS LTD. (IL) 2011-06-16 WO disclosed
WO-2010052718-A1 OXIDIZED LIPID COMPOUNDS AND USES THEREOF VASCULAR BIOGENICS LTD. (IL) 2010-05-14 WO disclosed